Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy

Cancer is the second most frequent cause of death worldwide, with 28.4 million new cases expected for 2040. Despite de advances in the treatment, it remains a challenge because of the tumor heterogenicity and the increase in multidrug resistance mechanisms. Thus, gene therapy has been a potential th...

Descripción completa

Detalles Bibliográficos
Autores principales: Luiz, Marcela Tavares, Dutra, Jessyca Aparecida Paes, Tofani, Larissa Bueno, de Araújo, Jennifer Thayanne Cavalcante, Di Filippo, Leonardo Delello, Marchetti, Juliana Maldonado, Chorilli, Marlus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030342/
https://www.ncbi.nlm.nih.gov/pubmed/35456655
http://dx.doi.org/10.3390/pharmaceutics14040821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030342/
https://www.ncbi.nlm.nih.gov/pubmed/35456655
http://dx.doi.org/10.3390/pharmaceutics14040821

Ejemplares similares